Casani AP, Navari E, Albera R, Agus G, Asprella Libonati G, Chiarella G, Lombardo N, Marcelli V, Ralli G, Scotto di Santillo L, Teggi R, Viola P, Califano L

Clinical Pharmacology: Advances and Applications 2019, 11:117-125

Published Date: 1 August 2019

Original Research

Role of the pharmacist in improving inhaler technique and asthma management in rural areas in Jordan

Basheti IA, Salhi YB, Basheti MM, Hamadi SA, Al-Qerem W

Clinical Pharmacology: Advances and Applications 2019, 11:103-116

Published Date: 23 July 2019

Original Research

Bioavailability and swallowability of an age-appropriate, delayed-release mesalamine formulation in healthy volunteers

Jakate A, McNamee B, Burkindine D

Clinical Pharmacology: Advances and Applications 2019, 11:93-101

Published Date: 12 July 2019

Review

Novel approaches to treating advanced systemic mastocytosis

Gilreath JA, Tchertanov L, Deininger MW

Clinical Pharmacology: Advances and Applications 2019, 11:77-92

Published Date: 10 July 2019

Original Research

Reproducibility of nasal allergen challenge responses in adults with allergic rhinitis

Pantin CT, Southworth T, Wetzel K, Singh D

Clinical Pharmacology: Advances and Applications 2019, 11:67-76

Published Date: 13 May 2019

Review

Current perspective on the role of insulin and glucagon in the pathogenesis and treatment of type 2 diabetes mellitus

Ojha A, Ojha U, Mohammed R, Chandrashekar A, Ojha H

Clinical Pharmacology: Advances and Applications 2019, 11:57-65

Published Date: 9 May 2019

Original Research

Effects of formulation types on pharmacodynamics of warfarin in patients with cerebral infarction and dysphagia

Kim YJ, Jeong JW, Song Y, Koo TS

Clinical Pharmacology: Advances and Applications 2019, 11:51-56

Published Date: 13 March 2019

Original Research

Modeling and simulation of the endogenous CYP3A induction marker 4β-hydroxycholesterol during enasidenib treatment

Li Y, Connarn JN, Chen J, Tong Z, Palmisano M, Zhou S

Clinical Pharmacology: Advances and Applications 2019, 11:39-50

Published Date: 15 February 2019

Original Research

Assessing the effect of omega-3 fatty acid combined with vitamin D3 versus vitamin D3 alone on estradiol levels: a randomized, placebo-controlled trial in females with vitamin D deficiency

Al-Shaer AH, Abu-Samak MS, Hasoun LZ, Mohammad BA, Basheti IA

Clinical Pharmacology: Advances and Applications 2019, 11:25-37

Published Date: 4 February 2019

Original Research

Small-cell lung cancer growth inhibition: synergism between NMDA receptor blockade and chemotherapy

North WG, Liu F, Dragnev KH, Demidenko E

Clinical Pharmacology: Advances and Applications 2019, 11:15-23

Published Date: 23 January 2019

Methodology

Method development and validation of ursodiol and its major metabolites in human plasma by HPLC-tandem mass spectrometry

Pinto MC, Chorfi Berton D, Cavenatti de Oliveira A, Lazaro CM, Aparecida Calafatti Carandina S

Clinical Pharmacology: Advances and Applications 2019, 11:1-13

Published Date: 4 January 2019

Original Research

Correlation between measured and calculated free phenytoin serum concentration in neurointensive care patients with hypoalbuminemia

Javadi SS, Mahjub R, Taher A, Mohammadi Y, Mehrpooya M

Clinical Pharmacology: Advances and Applications 2018, 10:183-190

Published Date: 13 December 2018

Original Research

Treatment of acne with a combination of propolis, tea tree oil, and Aloe vera compared to erythromycin cream: two double-blind investigations

Mazzarello V, Donadu MG, Ferrari M, Piga G, Usai D, Zanetti S, Sotgiu MA

Clinical Pharmacology: Advances and Applications 2018, 10:175-181

Published Date: 13 December 2018

Original Research

Species difference in paclitaxel disposition correlated with poor pharmacological efficacy translation from mice to humans

Li YF, Zhang C, Zhou S, He M, Zhang H, Chen N, Li F, Luan X, Pai M, Yuan H, Sun D, Li Y

Clinical Pharmacology: Advances and Applications 2018, 10:165-174

Published Date: 8 November 2018

Original Research

Evaluation of the single-dose pharmacokinetics and pharmacodynamics of apixaban in healthy Japanese and Caucasian subjects

Frost C, Shenker A, Jhee S, Yu Z, Wang J, Bragat A, Pursley J, LaCreta F

Clinical Pharmacology: Advances and Applications 2018, 10:153-163

Published Date: 24 October 2018

Original Research

12-month effects of incretins versus SGLT2-Inhibitors on cognitive performance and metabolic profile. A randomized clinical trial in the elderly with Type-2 diabetes mellitus

Perna S, Mainardi M, Astrone P, Gozzer C, Biava A, Bacchio R, Spadaccini D, Solerte SB, Rondanelli M

Clinical Pharmacology: Advances and Applications 2018, 10:141-151

Published Date: 9 October 2018

Original Research

The effect of combined treatment with sodium phenylbutyrate and cisplatin, erlotinib, or gefitinib on resistant NSCLC cells

Al-Keilani MS, Alzoubi KH, Jaradat SA

Clinical Pharmacology: Advances and Applications 2018, 10:135-140

Published Date: 9 October 2018

Review

Mechanisms and the clinical relevance of complex drug–drug interactions

Roberts AG, Gibbs ME

Clinical Pharmacology: Advances and Applications 2018, 10:123-134

Published Date: 27 September 2018

Original Research

Targeting EGFR and uPAR on human rhabdomyosarcoma, osteosarcoma, and ovarian adenocarcinoma with a bispecific ligand-directed toxin

Oh F, Todhunter D, Taras E, Vallera DA, Borgatti A

Clinical Pharmacology: Advances and Applications 2018, 10:113-121

Published Date: 26 September 2018

Original Research

Pharmacokinetics of evocalcet in secondary hyperparathyroidism patients receiving hemodialysis: first-in-patient clinical trial in Japan

Shigematsu T, Shimazaki R, Fukagawa M, Akizawa T

Clinical Pharmacology: Advances and Applications 2018, 10:101-111

Published Date: 11 September 2018

Original Research

A Phase I, open-label, randomized, crossover study in healthy subjects to evaluate the bioavailability of, and the food effect on, a pomalidomide oral liquid suspension

Li Y, Liu L, Huang L, Wang X, Hoffmann M, Reyes J, Palmisano M, Zhou S

Clinical Pharmacology: Advances and Applications 2018, 10:89-99

Published Date: 19 July 2018

Original Research

Safety and neutralizing rabies antibody in healthy subjects given a single dose of rabies immune globulin caprylate/chromatography purified

Hanna K, Cruz MC, Mondou E, Corsi E, Vandeberg P

Clinical Pharmacology: Advances and Applications 2018, 10:79-88

Published Date: 26 June 2018

Original Research

Pharmacokinetic evaluation of D-ribose after oral and intravenous administration to healthy rabbits

Alzoubi KH, Ismail ZB, AL-Essa MK, Alshogran OY, Abutayeh RF, Abu-Baker N

Clinical Pharmacology: Advances and Applications 2018, 10:73-78

Published Date: 12 June 2018

Corrigendum

A randomized direct comparison of the pharmacokinetics and pharmacodynamics of apixaban and rivaroxaban [Corrigendum]

Frost C, Song Y, Barrett YC, Wang J, Pursley J, Boyd RA, LaCreta F

Clinical Pharmacology: Advances and Applications 2018, 10:71-72

Published Date: 11 June 2018

Original Research

Anti-factor Xa levels in obese patients receiving enoxaparin for treatment and prophylaxis indications

Tahaineh L, Edaily SM, Gharaibeh SF

Clinical Pharmacology: Advances and Applications 2018, 10:63-70

Published Date: 18 May 2018

Original Research

Distribution of pomalidomide into semen of healthy male subjects after multiple doses

Li Y, Wang X, Liu L, Reyes J, Palmisano M, Zhou S

Clinical Pharmacology: Advances and Applications 2018, 10:53-62

Published Date: 7 May 2018

Original Research

Pharmacokinetic equivalence study of nonsteroidal anti-inflammatory drug etoricoxib

Tjandrawinata RR, Setiawati A, Nofiarny D, Susanto LW, Setiawati E

Clinical Pharmacology: Advances and Applications 2018, 10:43-51

Published Date: 6 April 2018

Review

Safinamide: an add-on treatment for managing Parkinson’s disease

Müller T

Clinical Pharmacology: Advances and Applications 2018, 10:31-41

Published Date: 5 April 2018

Original Research

Pramlintide, an antidiabetic, is antineoplastic in colorectal cancer and synergizes with conventional chemotherapy

Al-Keilani MS, Alsmadi DH, Darweesh RS, Alzoubi KH

Clinical Pharmacology: Advances and Applications 2018, 10:23-29

Published Date: 5 March 2018

Review

A review of the pharmacology and clinical efficacy of brivaracetam

Klein P, Diaz A, Gasalla T, Whitesides J

Clinical Pharmacology: Advances and Applications 2018, 10:1-22

Published Date: 19 January 2018

Review

CRTH2 antagonists in asthma: current perspectives

Singh D, Ravi A, Southworth T

Clinical Pharmacology: Advances and Applications 2017, 9:165-173

Published Date: 15 December 2017

Review

Olaratumab: a platelet-derived growth factor receptor-α-blocking antibody for the treatment of soft tissue sarcoma

Pender A, Jones RL

Clinical Pharmacology: Advances and Applications 2017, 9:159-164

Published Date: 4 December 2017

Review

Role of afatinib in the treatment of advanced lung squamous cell carcinoma

Vavalà T

Clinical Pharmacology: Advances and Applications 2017, 9:147-157

Published Date: 27 November 2017

Original Research

Population pharmacokinetics of pomalidomide in patients with relapsed or refractory multiple myeloma with various degrees of impaired renal function

Li Y, Wang X, O’Mara E, Dimopoulos MA, Sonneveld P, Weisel KC, Matous J, Siegel DS, Shah JJ, Kueenburg E, Sternas L, Cavanaugh C, Zaki M, Palmisano M, Zhou S

Clinical Pharmacology: Advances and Applications 2017, 9:133-145

Published Date: 8 November 2017

Original Research

Assessment of prescribed medications and pattern of distribution for potential drug–drug interactions among chronic kidney disease patients attending the Nephrology Clinic of Lagos University Teaching Hospital in Sub-Saharan West Africa

Fasipe OJ, Akhideno PE, Nwaiwu O, Adelosoye AA

Clinical Pharmacology: Advances and Applications 2017, 9:125-132

Published Date: 26 October 2017

Original Research

Possible involvement of ROS generation in vorinostat pretreatment induced enhancement of the antibacterial activity of ciprofloxacin

Masadeh MM, Alzoubi KH, Al-azzam SI, Al-buhairan AM

Clinical Pharmacology: Advances and Applications 2017, 9:119-124

Published Date: 17 October 2017

Original Research

Antipsychotic prescription to identify delirium: results from two cohorts

Zimmerman KM, Paquin AM, Rudolph JL

Clinical Pharmacology: Advances and Applications 2017, 9:113-117

Published Date: 3 October 2017

Review

Practical recommendations for the use of therapeutic drug monitoring of biopharmaceuticals in inflammatory diseases

Dreesen E, Bossuyt P, Mulleman D, Gils A, Pascual-Salcedo D

Clinical Pharmacology: Advances and Applications 2017, 9:101-111

Published Date: 3 October 2017

Original Research

Etanercept (Enbrel®) alternative storage at ambient temperature

Shannon E, Daffy J, Jones H, Paulson A, Vicik SM

Clinical Pharmacology: Advances and Applications 2017, 9:87-99

Published Date: 21 July 2017

Original Research

NMDA receptors are important regulators of pancreatic cancer and are potential targets for treatment

North WG, Liu F, Lin LZ, Tian R, Akerman B

Clinical Pharmacology: Advances and Applications 2017, 9:79-86

Published Date: 17 July 2017

Original Research

Adverse reactions in leprosy patients who underwent dapsone multidrug therapy: a retrospective study

Guragain S, Upadhayay N, Bhattarai BM

Clinical Pharmacology: Advances and Applications 2017, 9:73-78

Published Date: 29 June 2017

Original Research

Prediction of efficacy for conversion from adjunctive therapy to monotherapy with eslicarbazepine acetate 800 mg once daily for partial-onset epilepsy

Sunkaraneni S, Passarell JA, Ludwig EA, Fiedler-Kelly J, Pitner JK, Grinnell TA, Blum D

Clinical Pharmacology: Advances and Applications 2017, 9:65-72

Published Date: 27 June 2017

Original Research

An integrated epidemiological and neural net model of the warfarin effect in managed care patients

Jacobs DM, Stefanovic F, Wilton G, Gomez-Caminero A, Schentag JJ

Clinical Pharmacology: Advances and Applications 2017, 9:55-64

Published Date: 18 May 2017

Original Research

Comparative analysis of the safety and tolerability of fixed-dose artesunate/amodiaquine versus artemether/lumefantrine combinations for uncomplicated falciparum malaria in pregnancy: a randomized open label study

Iribhogbe OI, Emmanuel I, Odianosen M

Clinical Pharmacology: Advances and Applications 2017, 9:45-54

Published Date: 9 May 2017

Original Research

Pharmacokinetics and outcome of tazobactam/piperacillin in Japanese patients undergoing low-flow continuous renal replacement therapy: dosage considerations

Kohama H, Ide T, Ikawa K, Morikawa N, Nishi S

Clinical Pharmacology: Advances and Applications 2017, 9:39-44

Published Date: 24 February 2017

Original Research

Pharmaceutical characterization of novel tenofovir liposomal formulations for enhanced oral drug delivery: in vitro pharmaceutics and Caco-2 permeability investigations

Spinks CB, Zidan AS, Khan MA, Habib MJ, Faustino PJ

Clinical Pharmacology: Advances and Applications 2017, 9:29-38

Published Date: 23 February 2017

Original Research

The effect of apixaban on the pharmacokinetics of digoxin and atenolol in healthy subjects

Frost C, Song Y, Yu Z, Wang J, Lee LS, Schuster A, Pollack A, LaCreta F

Clinical Pharmacology: Advances and Applications 2017, 9:19-28

Published Date: 23 February 2017

Original Research

Effect of food on the pharmacokinetics of dronabinol oral solution versus dronabinol capsules in healthy volunteers

Oh DA, Parikh N, Khurana V, Cognata Smith C, Vetticaden S

Clinical Pharmacology: Advances and Applications 2017, 9:9-17

Published Date: 11 January 2017

Original Research

Retrospective analysis of the effects of a highly standardized mixture of Berberis aristata, Silybum marianum, and monacolins K and KA in patients with dyslipidemia

Di Pierro F, Putignano P, Ferrara T, Raiola C, Rapacioli G, Villanova N

Clinical Pharmacology: Advances and Applications 2017, 9:1-7

Published Date: 21 December 2016

Original Research

A Phase I study evaluating the effect of age and weight on the pharmacokinetics of an injectable formulation of diclofenac solubilized with hydroxypropyl-β-cyclodextrin

Goldwater R, Kramer WG, Hamilton DA, Lang E, Wang J, Madden DE, Lacouture PG, Ramaiya A, Carr DB

Clinical Pharmacology: Advances and Applications 2016, 8:203-212

Published Date: 15 December 2016

Case report

A case of probable esomeprazole-induced transient liver injury in a pregnant woman with hyperemesis

Thomas B, Mohamed M, Al Hail M, Awwad FA, Wahba RM, Hassan SB, Omar K, El Kassem W, Abdul Rouf P

Clinical Pharmacology: Advances and Applications 2016, 8:199-202

Published Date: 13 December 2016

Original Research

A prospective, observational study comparing the PK/PD relationships of generic Meropenem (Mercide®) to the innovator brand in critically ill patients

Mer M, Snyman JR, van Rensburg CEJ, van Tonder JJ, Laurens I

Clinical Pharmacology: Advances and Applications 2016, 8:191-198

Published Date: 17 November 2016

Review

LRRK2 inhibitors and their potential in the treatment of Parkinson’s disease: current perspectives

Atashrazm F, Dzamko N

Clinical Pharmacology: Advances and Applications 2016, 8:177-189

Published Date: 20 October 2016

Review

Skin models for the testing of transdermal drugs

Abd E, Yousuf SA, Pastore MN, Telaprolu K, Mohammed YH, Namjoshi S, Grice JE, Roberts MS

Clinical Pharmacology: Advances and Applications 2016, 8:163-176

Published Date: 19 October 2016

Original Research

Bioavailability study of dronabinol oral solution versus dronabinol capsules in healthy volunteers

Parikh N, Kramer WG, Khurana V, Cognata Smith C, Vetticaden S

Clinical Pharmacology: Advances and Applications 2016, 8:155-162

Published Date: 12 October 2016

Original Research

Glibenclamide population pharmacokinetic/pharmacodynamic modeling in South African type 2 diabetic subjects

Rambiritch V, Naidoo P, Pillai G

Clinical Pharmacology: Advances and Applications 2016, 8:141-153

Published Date: 26 September 2016

Review

Cystic fibrosis transmembrane conductance regulator modulators in cystic fibrosis: current perspectives

Schmidt BZ, Haaf JB, Leal T, Noel S

Clinical Pharmacology: Advances and Applications 2016, 8:127-140

Published Date: 21 September 2016

Original Research

Exposure-response analysis to assess concentration–QTc relationship of CC-122

Li Y, Carayannopoulos LN,Thomas M, Palmisano M, Zhou S

Clinical Pharmacology: Advances and Applications 2016, 8:117-125

Published Date: 9 September 2016

Original Research

The effect of weight, body mass index, age, sex , and race on plasma concentrations of subcutaneous sumatriptan: a pooled analysis

Munjal S, Gautam A, Rapoport AM, Fisher DM

Clinical Pharmacology: Advances and Applications 2016, 8:109-116

Published Date: 1 September 2016

Original Research

Systematic review and network meta-analysis of stroke prevention treatments in patients with atrial fibrillation

Tawfik A, Bielecki JM, Krahn M, Dorian P, Hoch JS, Boon H, Husereau D, Pechlivanoglou P

Clinical Pharmacology: Advances and Applications 2016, 8:93-107

Published Date: 11 August 2016

Original Research

Population pharmacokinetic modeling of glibenclamide in poorly controlled South African type 2 diabetic subjects

Rambiritch V, Naidoo P, Maharaj B, Pillai G

Clinical Pharmacology: Advances and Applications 2016, 8:83-92

Published Date: 12 July 2016

Review

The treatment of type 2 diabetes in the presence of renal impairment: what we should know about newer therapies

Davies M, Chatterjee S, Khunti K

Clinical Pharmacology: Advances and Applications 2016, 8:61-81

Published Date: 23 June 2016

Original Research

A randomized, double-blind, placebo-, and positive-controlled clinical pilot study to evaluate the efficacy and tolerability of standardized aqueous extracts of Terminalia chebula and Terminalia bellerica in subjects with hyperuricemia

Usharani P, Nutalapati C, Pokuri VK, Kumar CU, Taduri G

Clinical Pharmacology: Advances and Applications 2016, 8:51-59

Published Date: 22 June 2016

Original Research

Simultaneous administration of high-dose atorvastatin and clopidogrel does not interfere with platelet inhibition during percutaneous coronary intervention

Kreutz RP, Breall JA, Sinha A, von der Lohe E, Kovacs RJ, Flockhart DA

Clinical Pharmacology: Advances and Applications 2016, 8:45-50

Published Date: 3 June 2016

Review

Clinical use and applications of histone deacetylase inhibitors in multiple myeloma

Tandon N, Ramakrishnan V, Kumar SK

Clinical Pharmacology: Advances and Applications 2016, 8:35-44

Published Date: 6 May 2016

Review

Differential pharmacology and clinical utility of empagliflozin in type 2 diabetes

Munir KM, Davis SN

Clinical Pharmacology: Advances and Applications 2016, 8:19-34

Published Date: 20 April 2016

Original Research

Pharmacokinetic/pharmacodynamic analysis of teicoplanin in patients with MRSA infections

Matsumoto K, Watanabe E, Kanazawa N, Fukamizu T, Shigemi A, Yokoyama Y, Ikawa K, Morikawa N, Takeda Y

Clinical Pharmacology: Advances and Applications 2016, 8:15-18

Published Date: 30 March 2016

Original Research

Pharmacokinetics of daclizumab high-yield process with repeated administration of the clinical subcutaneous regimen in patients with relapsing-remitting multiple sclerosis

Tran JQ, Othman AA, Mikulskis A, Wolstencroft P, Elkins J

Clinical Pharmacology: Advances and Applications 2016, 8:9-13

Published Date: 11 February 2016

Review

Pharmacokinetics and safety of posaconazole delayed-release tablets for invasive fungal infections

Wiederhold NP

Clinical Pharmacology: Advances and Applications 2016, 8:1-8

Published Date: 23 December 2015

Original Research

NMDA receptors are expressed in human ovarian cancer tissues and human ovarian cancer cell lines

North WG, Liu F, Tian R, Abbasi H, Akerman B

Clinical Pharmacology: Advances and Applications 2015, 7:111-117

Published Date: 23 October 2015

Original Research

A clinical evaluation to determine the safety, pharmacokinetics, and pharmacodynamics of an inositol-stabilized arginine silicate dietary supplement in healthy adult males

Kalman DS, Feldman S, Samson A, Krieger DR

Clinical Pharmacology: Advances and Applications 2015, 7:103-109

Published Date: 7 October 2015

Original Research

Addition of a renin-angiotensin-aldosterone system inhibitor to a calcium channel blocker ameliorates arterial stiffness

Kiuchi S, Hisatake S, Kawasaki M, Hirashima O, Kabuki T, Yamazaki J, Ikeda T

Clinical Pharmacology: Advances and Applications 2015, 7:97-102

Published Date: 8 October 2015

Original Research

An exploratory, randomized, parallel-group, open-label, relative bioavailability study with an additional two-period crossover food-effect study exploring the pharmacokinetics of two novel formulations of pexmetinib (ARRY-614)

Wollenberg LA, Corson DT, Nugent CA, Peterson FL, Ptaszynski AM, Arrigo A, Mannila CG, Litwiler KS, Bell SJ

Clinical Pharmacology: Advances and Applications 2015, 7:87-95

Published Date: 30 September 2015

Case report

Tizanidine-induced acute severe cystitis in a female taking famotidine

Poudel RR, Kafle NK

Clinical Pharmacology: Advances and Applications 2015, 7:83-85

Published Date: 29 July 2015

Original Research

Pharmacokinetics and skin-tissue penetration of daptomycin in rats

Matsumoto K, Kitaoka M, Kuroda Y, Ikawa K, Morikawa N, Sasaki J, Iketani O, Iwata S, Horino T, Hori S, Kizu J

Clinical Pharmacology: Advances and Applications 2015, 7:79-82

Published Date: 21 May 2015

Letter

Pharmacodynamics and Pharmacokinetics of oral factor Xa inhibitors

Persson PB

Clinical Pharmacology: Advances and Applications 2015, 7:77-78

Published Date: 11 May 2015

Original Research

Pharmacokinetic equivalence study of two formulations of the anticonvulsant pregabalin

Tjandrawinata RR, Setiawati E, Putri RSI, Gunawan VA, Ong F, Susanto LW, Nofiarny D

Clinical Pharmacology: Advances and Applications 2015, 7:69-75

Published Date: 20 April 2015

Review

Expanding antitumor therapeutic windows by targeting cancer-specific nicotinamide adenine dinucleotide phosphate-biogenesis pathways

Chakrabarti G, Gerber DE, Boothman DA

Clinical Pharmacology: Advances and Applications 2015, 7:57-68

Published Date: 27 March 2015

Review

Carbon monoxide: a critical quantitative analysis and review of the extent and limitations of its second messenger function

Levitt DG, Levitt MD

Clinical Pharmacology: Advances and Applications 2015, 7:37-56

Published Date: 26 February 2015

Original Research

Severe iatrogenic bradycardia related to the combined use of beta-blocking agents and sodium channel blockers

Kawabata M, Yokoyama Y, Sasaki T, Tao S, Ihara K, Shirai Y, Sasano T, Goya M, Furukawa T, Isobe M, Hirao K

Clinical Pharmacology: Advances and Applications 2015, 7:29-36

Published Date: 16 February 2015

Original Research

Heparin requirements for full anticoagulation are higher for patients on dabigatran than for those on warfarin – a model-based study

Edrich T, Frendl G, Michaud G, Paschalidis I Ch

Clinical Pharmacology: Advances and Applications 2015, 7:19-27

Published Date: 5 February 2015

Original Research

Bioavailability of everolimus administered as a single 5 mg tablet versus five 1 mg tablets: a randomized, open-label, two-way crossover study of healthy volunteers

Thudium K, Gallo J, Bouillaud E, Sachs C, Eddy S, Cheung W

Clinical Pharmacology: Advances and Applications 2015, 7:11-17

Published Date: 22 January 2015

Original Research

Effects of food and alcohol on the pharmacokinetics of an oral, extended-release formulation of hydrocodone in healthy volunteers

Farr SJ, Robinson CY, Rubino CM

Clinical Pharmacology: Advances and Applications 2015, 7:1-9

Published Date: 19 January 2015

Original Research

Enantiomer-selective pharmacokinetics, oral bioavailability, and sex effects of various alpha-lipoic acid dosage forms

Hermann R, Mungo J, Cnota PJ, Ziegler D

Clinical Pharmacology: Advances and Applications 2014, 6:195-204

Published Date: 28 November 2014

Perspectives

Parkinson's disease: carbidopa, nausea, and dyskinesia

Hinz M, Stein A, Cole T

Clinical Pharmacology: Advances and Applications 2014, 6:189-194

Published Date: 14 November 2014

Original Research

A randomized direct comparison of the pharmacokinetics and pharmacodynamics of apixaban and rivaroxaban

Frost C, Song Y, Barrett YC, Wang J, Pursley J, Boyd RA, LaCreta F

Clinical Pharmacology: Advances and Applications 2014, 6:179-187

Published Date: 13 November 2014

Original Research

Evaluating the effects of dexmedetomidine compared to propofol as adjunctive therapy in patients with alcohol withdrawal

Lizotte RJ, Kappes JA, Bartel BJ, Hayes KM, Lesselyoung VL

Clinical Pharmacology: Advances and Applications 2014, 6:171-177

Published Date: 31 October 2014

Perspectives

The Parkinson's disease death rate: carbidopa and vitamin B6

Hinz M, Stein A, Cole T

Clinical Pharmacology: Advances and Applications 2014, 6:161-169

Published Date: 21 October 2014

Original Research

Lack of effect of ezogabine/retigabine on the pharmacokinetics of digoxin in healthy individuals: results from a drug–drug interaction study

Tompson DJ, Crean CS, Buraglio M, Arumugham T

Clinical Pharmacology: Advances and Applications 2014, 6:149-159

Published Date: 13 October 2014

Review

Arbekacin: another novel agent for treating infections due to methicillin-resistant Staphylococcus aureus and multidrug-resistant Gram-negative pathogens

Matsumoto T

Clinical Pharmacology: Advances and Applications 2014, 6:139-148

Published Date: 26 September 2014

Review

Melatonergic drugs in development

Carocci A, Catalano A, Sinicropi MS

Clinical Pharmacology: Advances and Applications 2014, 6:127-137

Published Date: 18 September 2014

Review

Reducing medication errors in critical care: a multimodal approach

Kruer RM, Jarrell AS, Latif A

Clinical Pharmacology: Advances and Applications 2014, 6:117-126

Published Date: 1 September 2014

Review

Differential renal adverse effects of ibuprofen and indomethacin in preterm infants: a review

Pacifici GM

Clinical Pharmacology: Advances and Applications 2014, 6:111-116

Published Date: 31 July 2014

Review

Administration of supplemental L-tyrosine with phenelzine: a clinical literature review

Hinz M, Stein A, Cole T, Ryan P

Clinical Pharmacology: Advances and Applications 2014, 6:107-110

Published Date: 22 July 2014

Original Research

Effect of age and sex on warfarin dosing

Khoury G, Sheikh-Taha M

Clinical Pharmacology: Advances and Applications 2014, 6:103-106

Published Date: 12 July 2014

Original Research

In vitro microdialysis membrane efficiency of broad-spectrum antibiotics in combination and alone

MacVane SH, Housman ST, Nicolau DP

Clinical Pharmacology: Advances and Applications 2014, 6:97-101

Published Date: 5 June 2014

Review

Incidence and management of adverse events in patients with relapsed and/or refractory multiple myeloma receiving single-agent carfilzomib

Harvey RD

Clinical Pharmacology: Advances and Applications 2014, 6:87-96

Published Date: 8 May 2014

Original Research

Effects of irbesartan on serum uric acid levels in patients with hypertension and diabetes

Nakamura M, Sasai N, Hisatome I, Ichida K

Clinical Pharmacology: Advances and Applications 2014, 6:79-86

Published Date: 3 May 2014

Original Research

Analysis of factors affecting rehospitalization of patients with chronic kidney disease after educational hospitalization

Kose E, An T, Kikkawa A, Matsumoto Y, Hayashi H

Clinical Pharmacology: Advances and Applications 2014, 6:71-78

Published Date: 8 April 2014

Original Research

Glibenclamide in patients with poorly controlled type 2 diabetes: a 12-week, prospective, single-center, open-label, dose-escalation study

Rambiritch V, Maharaj B, Naidoo P

Clinical Pharmacology: Advances and Applications 2014, 6:63-69

Published Date: 4 April 2014

Corrigendum

Single- and multiple-dose pharmacokinetics, pharmacodynamics, and safety of apixaban in healthy Chinese subjects [Corrigendum]

Cui Y, Song Y, Wang J, Yu Z, Schuster A, Barrett YC, Frost C

Clinical Pharmacology: Advances and Applications 2014, 6:61-62

Published Date: 27 March 2014

Original Research

Pharmacokinetics and pharmacodynamics of acetylsalicylic acid after intravenous and oral administration to healthy volunteers

Nagelschmitz J, Blunck M, Kraetzschmar J, Ludwig M, Wensing G, Hohlfeld T

Clinical Pharmacology: Advances and Applications 2014, 6:51-59

Published Date: 19 March 2014

Original Research

Population pharmacokinetics of olprinone in healthy male volunteers

Kunisawa T, Kasai H, Suda M, Yoshimura M, Sugawara A, Izumi Y, Iida T, Kurosawa A, Iwasaki H

Clinical Pharmacology: Advances and Applications 2014, 6:43-50

Published Date: 4 March 2014

Review

Pathophysiological processes in multiple sclerosis: focus on nuclear factor erythroid-2-related factor 2 and emerging pathways

Arnold P, Mojumder D, DeToledo J, Lucius R, Wilms H

Clinical Pharmacology: Advances and Applications 2014, 6:35-42

Published Date: 24 February 2014

Review

The clinical potential of influencing Nrf2 signaling in degenerative and immunological disorders

Gao B, Doan A, Hybertson BM

Clinical Pharmacology: Advances and Applications 2014, 6:19-34

Published Date: 3 February 2014

Review

Chronic hepatitis C: future treatment

Wendt A, Adhoute X, Castellani P, Oules V, Ansaldi C, Benali S, Bourlière M

Clinical Pharmacology: Advances and Applications 2014, 6:1-17

Published Date: 8 January 2014

Original Research

Hemodialysis does not alter in vitro hepatic CYP3A4 and CYP2D6 metabolic activity in uremic serum

Decker BS, O’Neill KD, Chambers MA, Slaven JE, Yu Z, Jones DR, Moe SM

Clinical Pharmacology: Advances and Applications 2013, 5:193-199

Published Date: 10 December 2013

Original Research

Cytochrome P450 3A4*22, PPAR-α, and ARNT polymorphisms and clopidogrel response

Kreutz RP, Owens J, Jin Y, Nystrom P, Desta Z, Kreutz Y, Breall JA, Li L, Chiang CW, Kovacs RJ, Flockhart DA

Clinical Pharmacology: Advances and Applications 2013, 5:185-192

Published Date: 9 December 2013

Original Research

Single- and multiple-dose pharmacokinetics, pharmacodynamics, and safety of apixaban in healthy Chinese subjects

Cui Y, Song Y, Wang J, Yu Z, Schuster A, Barrett YC, Frost C

Clinical Pharmacology: Advances and Applications 2013, 5:177-184

Published Date: 6 December 2013

Corrigendum

Atazanavir–bilirubin interaction: a pharmacokinetic–pharmacodynamic model [Corrigendum]

Lozano R, Domeque N, Apesteguia AF

Clinical Pharmacology: Advances and Applications 2013, 5:175-176

Published Date: 22 November 2013

Original Research

Preliminary study about the possible glycemic clinical advantage in using a fixed combination of Berberis aristata and Silybum marianum standardized extracts versus only Berberis aristata in patients with type 2 diabetes

Di Pierro F, Putignano P, Villanova N, Montesi L, Moscatiello S, Marchesini G

Clinical Pharmacology: Advances and Applications 2013, 5:167-174

Published Date: 19 November 2013

Case Series

High-dose, short-interval daptomycin regimen was safe and well tolerated in three patients with chronic renal failure

Yabuno K, Seki M, Miyawaki K, Miwa Y, Tomono K

Clinical Pharmacology: Advances and Applications 2013, 5:161-166

Published Date: 5 November 2013

Original Research

Atazanavir–bilirubin interaction: a pharmacokinetic–pharmacodynamic model

Lozano R, Domeque N, Apesteguia AF

Clinical Pharmacology: Advances and Applications 2013, 5:153-159

Published Date: 27 September 2013

Letter

Reviews of botulinum toxin products in aesthetic use must be accurate, clear and avoid speculation

Pickett A

Clinical Pharmacology: Advances and Applications 2013, 5:149-152

Published Date: 5 September 2013

Review

Comparative safety and efficacy of antithrombotics in the management of venous thromboembolism after knee or hip replacement surgery: focus on rivaroxaban

Kwong LM

Clinical Pharmacology: Advances and Applications 2013, 5:143-148

Published Date: 2 August 2013

Review

Single-dose fentanyl sublingual spray for breakthrough cancer pain

Taylor DR

Clinical Pharmacology: Advances and Applications 2013, 5:131-141

Published Date: 24 July 2013

Review

Impact of denosumab on bone mass in cancer patients

Brown-Glaberman U, Stopeck AT

Clinical Pharmacology: Advances and Applications 2013, 5:117-129

Published Date: 4 July 2013

Review

Synthetic cathinone abuse

Capriola M

Clinical Pharmacology: Advances and Applications 2013, 5:109-115

Published Date: 2 July 2013

Review

Clinical effectiveness of baclofen for the treatment of alcohol dependence: a review

Brennan JL, Leung JG, Gagliardi JP, Rivelli SK, Muzyk AJ

Clinical Pharmacology: Advances and Applications 2013, 5:99-107

Published Date: 3 July 2013

Original Research

Differential effects of dosing regimen on the safety and efficacy of dasatinib: retrospective exposure–response analysis of a Phase III study

Wang X, Roy A, Hochhaus A, Kantarjian HM, Chen TT, Shah NP

Clinical Pharmacology: Advances and Applications 2013, 5:85-97

Published Date: 10 June 2013

Review

Advances in antiplatelet technologies to improve cardiovascular disease morbidity and mortality: a review of ticagrelor

Davis EM, Knezevich JT, Teply RM

Clinical Pharmacology: Advances and Applications 2013, 5:67-83

Published Date: 19 April 2013

Original Research

Effect of famotidine on the pharmacokinetics of apixaban, an oral direct factor Xa inhibitor

Upreti VV, Song Y, Wang J, Byon W, Boyd RA, Pursley JM, LaCreta F, Frost CE

Clinical Pharmacology: Advances and Applications 2013, 5:59-66

Published Date: 16 April 2013

Case report

Newly diagnosed congenital factor VII deficiency and utilization of recombinant activated factor VII (NovoSeven®)

Bartosh NS, Tomlin T, Cable C, Halka K

Clinical Pharmacology: Advances and Applications 2013, 5:53-58

Published Date: 15 March 2013

Review

Differential characteristics of incobotulinumtoxinA and its use in the management of glabellar frown lines

Prager W

Clinical Pharmacology: Advances and Applications 2013, 5:39-52

Published Date: 12 March 2013

Original Research

Effect of statin therapy on vaspin levels in type 2 diabetic patients

Al-Azzam SI, Alzoubi KH, Abu Abeeleh J, Mhaidat NM, Abu-Abeeleh M

Clinical Pharmacology: Advances and Applications 2013, 5:33-38

Published Date: 20 February 2013

Original Research

A Phase 1, randomized, open-label crossover study to evaluate the safety and pharmacokinetics of 400 mg albaconazole administered to healthy participants as a tablet formulation versus a capsule formulation

van Rossem K, Lowe JA

Clinical Pharmacology: Advances and Applications 2013, 5:23-31

Published Date: 30 January 2013

Corrigendum

Update on the management of ulcerative colitis: treatment and maintenance approaches focused on MMX® mesalamine. [Corrigendum]

Nanda K, Moss AC

Clinical Pharmacology: Advances and Applications 2013, 5:21-22

Published Date: 22 January 2013

Original Research

Arginine deprivation therapy for malignant melanoma

Yoon JK, Frankel AE, Feun LG, Ekmekcioglu S, Kim KB

Clinical Pharmacology: Advances and Applications 2013, 5:11-19

Published Date: 27 December 2012

Review

Advances in the management of glioblastoma: the role of temozolomide and MGMT testing

Thomas RP, Recht L, Nagpal S

Clinical Pharmacology: Advances and Applications 2013, 5:1-9

Published Date: 27 December 2012

Review

Epithelial cell-adhesion molecule-directed trifunctional antibody immunotherapy for symptom management of advanced ovarian cancer

Eskander RN, Tewari KS

Clinical Pharmacology: Advances and Applications 2013, 5:55-61

Published Date: 3 October 2013

Review

Immunotherapy of melanoma with the immune costimulatory monoclonal antibodies targeting CD137

Li SY, Liu Y

Clinical Pharmacology: Advances and Applications 2013, 5:47-53

Published Date: 2 September 2013

Review

Immunocytokines: a review of molecules in clinical development for cancer therapy

List T, Neri D

Clinical Pharmacology: Advances and Applications 2013, 5:29-45

Published Date: 20 August 2013

Review

Use of ipilimumab in the treatment of melanoma

Acharya UH, Jeter JM

Clinical Pharmacology: Advances and Applications 2013, 5:21-27

Published Date: 9 August 2013

Review

Toll-like receptor 8: augmentation of innate immunity in platinum resistant ovarian carcinoma

Brueseke TJ, Tewari KS

Clinical Pharmacology: Advances and Applications 2013, 5:13-19

Published Date: 23 May 2013

Review

Clinical and pharmacologic aspects of blinatumomab in the treatment of B-cell acute lymphoblastic leukemia

Portell CA, Wenzell CM, Advani AS

Clinical Pharmacology: Advances and Applications 2013, 5:5-11

Published Date: 12 April 2013

Editorial

Special issue of clinical pharmacology: advances and applications in new protein therapeutics modulating tumor immunity

Frankel AE

Clinical Pharmacology: Advances and Applications 2013, 5:1-3

Published Date: 26 November 2013

Original Research

Loading regimen required to rapidly achieve therapeutic trough plasma concentration of teicoplanin and evaluation of clinical features

Seki M, Yabuno K, Miyawaki K, Miwa Y, Tomono K

Clinical Pharmacology: Advances and Applications 2012, 4:71-75

Published Date: 27 November 2012

Review

Pazopanib for the treatment of soft-tissue sarcoma

Heudel P, Cassier P, Derbel O, Dufresne A, Meeus P, Thiesse P, Ranchère-Vince D, Blay JY, Ray-Coquard I

Clinical Pharmacology: Advances and Applications 2012, 4:65-70

Published Date: 26 October 2012

Review

Sedation in the intensive care setting

Hughes CG, McGrane S, Pandharipande PP

Clinical Pharmacology: Advances and Applications 2012, 4:53-63

Published Date: 25 October 2012

Erratum

Samtani MN, Sheehan JJ, Fu D-J, Remmerie B, Sliwa JK, Alphs L

Clinical Pharmacology: Advances and Applications 2012, 4:51-52

Published Date: 13 September 2012

Review

Update on the management of ulcerative colitis: treatment and maintenance approaches focused on MMX® mesalamine

Nanda K, Moss AC

Clinical Pharmacology: Advances and Applications 2012, 4:41-50

Published Date: 25 July 2012

Original Research

Management of antipsychotic treatment discontinuation and interruptions using model-based simulations

Samtani MN, Sheehan JJ, Fu D-J, Remmerie B, Sliwa JK, Alphs L

Clinical Pharmacology: Advances and Applications 2012, 4:25-40

Published Date: 16 July 2012

Erratum

Barrese V, Miceli F, Soldovieri MV, Ambrosino P, Iannotti FA, Cilio MR, Taglialatela M

Clinical Pharmacology: Advances and Applications 2012, 4:23-24

Published Date: 26 March 2012

Letter

Smoking cessation

Kaur K, Juneja S, Kaushal S

Clinical Pharmacology: Advances and Applications 2012, 4:21-22

Published Date: 15 March 2012

Original Research

Influence of paraoxonase-1 Q192R and cytochrome P450 2C19 polymorphisms on clopidogrel response

Kreutz RP, Nystrom P, Kreutz Y, Miao J, Desta Z, Breall JA, Li L, Chiang C, Kovacs R, Flockhart DA, Jin Y

Clinical Pharmacology: Advances and Applications 2012, 4:13-20

Published Date: 20 February 2012

Original Research

Phase 1 clinical study of the acute and subacute safety and proof-of-concept efficacy of carbohydrate-derived fulvic acid

Gandy JJ, Meeding JP, Snyman JR, Janse van Rensburg CE

Clinical Pharmacology: Advances and Applications 2012, 4:7-11

Published Date: 17 February 2012

Original Research

Nortriptyline versus fluoxetine in the treatment of major depressive disorder: a six-month, double-blind clinical trial

Hashemi SN, Ghafarian Shirazi HR, Mohammadi A, Zadeh-Bagheri GH, Noorian KH, Malekzadeh M

Clinical Pharmacology: Advances and Applications 2012, 4:1-6

Published Date: 27 January 2012

Review

Drug-resistant tuberculosis: emerging treatment options

Adhvaryu MR, Vakharia BC

Clinical Pharmacology: Advances and Applications 2011, 3:51-67

Published Date: 14 December 2011

Case report

Reduced dose maintenance eculizumab in atypical hemolytic uremic syndrome (aHUS): an update on a previous case report

Ohanian M, Cable C, Halka K

Clinical Pharmacology: Advances and Applications 2011, 3:45-50

Published Date: 1 November 2011

Case Series

Hepatotoxicity of tocilizumab and anakinra in rheumatoid arthritis: management decisions

Mahamid M, Mader R, Safadi R

Clinical Pharmacology: Advances and Applications 2011, 3:39-43

Published Date: 4 October 2011

Review

Detemir as a once-daily basal insulin in type 2 diabetes

Nelson SE

Clinical Pharmacology: Advances and Applications 2011, 3:27-37

Published Date: 18 August 2011

Original Research

Two-way pharmacokinetic interaction studies between saxagliptin and cytochrome P450 substrates or inhibitors: simvastatin, diltiazem extended-release, and ketoconazole

Patel C, Li L, Girgis S, Kornhauser D, Frevert E, Boulton D

Clinical Pharmacology: Advances and Applications 2011, 3:13-25

Published Date: 22 June 2011

Case report

Eculizumab safely reverses neurologic impairment and eliminates need for dialysis in severe atypical hemolytic uremic syndrome

Ohanian M, Cable CC, Halka KK

Clinical Pharmacology: Advances and Applications 2011, 3:5-12

Published Date: 24 May 2011

Case report

A case of cephalothin-associated urolithiasis

Ivan WM Lim, Peter JO Stride, Robert L Horvath

Clinical Pharmacology: Advances and Applications 2011, 3:1-3

Published Date: 28 February 2011

Review

Neuronal potassium channel openers in the management of epilepsy: role and potential of retigabine

Vincenzo Barrese, Francesco Miceli, Maria Virginia Soldovieri, et al

Clinical Pharmacology: Advances and Applications 2010, 2:225-236

Published Date: 7 December 2010

Other

Editorial Foreword

Arthur E Frankel

Clinical Pharmacology: Advances and Applications 2010, 2:223-224

Published Date: 25 November 2010

Review

Intrapleural therapy in management of complicated parapneumonic effusions and empyema

AlaEldin H Ahmed, Tariq E Yacoub

Clinical Pharmacology: Advances and Applications 2010, 2:213-221

Published Date: 22 November 2010

Original Research

Analgesic efficacy of oral gabapentin added to standard epidural corticosteroids in patients with failed back surgery

Beyazit Zencirci

Clinical Pharmacology: Advances and Applications 2010, 2:207-211

Published Date: 30 September 2010

Original Research

A comparative study of DNA damage in patients suffering from diabetes and thyroid dysfunction and complications

Nima V Thakkar, Sunita M Jain

Clinical Pharmacology: Advances and Applications 2010, 2:199-205

Published Date: 22 September 2010

Review

Mitochondrial therapy for Parkinson’s disease: Neuroprotective pharmaconutrition may be disease-modifying

Richard Kones

Clinical Pharmacology: Advances and Applications 2010, 2:185-198

Published Date: 17 September 2010

Other

In vitro cytotoxicity of combinations of dichloroacetate with anticancer platinum compounds

Ulrike Olszewski, Thomas Tuxen Poulsen, Ernst Ulsperger, et al

Clinical Pharmacology: Advances and Applications 2010, 2:177-183

Published Date: 14 September 2010

Original Research

Reporting of results of interventional studies by the information service of the National Institutes of Health

Tatyana Shamliyan

Clinical Pharmacology: Advances and Applications 2010, 2:169-176

Published Date: 10 September 2010

Original Research

Clinical efficacy of beta1 selective adrenergic blockers in the treatment of neurocardiogenic syncope – a meta-analysis

Srikanth Vallurupalli, Smita Das

Clinical Pharmacology: Advances and Applications 2010, 2:163-167

Published Date: 15 September 2010

Review

The interaction between clopidogrel and proton pump inhibitors (PPI): is there any clinical relevance?

Rakesh K Sharma, Hanumanth K Reddy, Rohit K Sharma, et al

Clinical Pharmacology: Advances and Applications 2010, 2:155-162

Published Date: 6 September 2010

Review

Testosterone replacement in male hypogonadism

Sanjay Kalra, Navneet Agrawal, Satish Kumar, et al

Clinical Pharmacology: Advances and Applications 2010, 2:149-153

Published Date: 10 September 2010

Original Research

Differences in hospital glycemic control and insulin requirements in patients recovering from critical illness and those without prior critical illness

April D Miller, Leslie M Phillips, Richard M Schulz, et al

Clinical Pharmacology: Advances and Applications 2010, 2:143-148

Published Date: 24 August 2010

Other

Rituximab in severe skin diseases: target, disease, and dose

Daniel D Bennett, Maro Ohanian, Christian T Cable

Clinical Pharmacology: Advances and Applications 2010, 2:135-141

Published Date: 7 July 2010

Mini-review

Managing insulin resistance: role of liraglutide

Sanjay Kalra, Bharti Kalra, Satish Kumar, et al

Clinical Pharmacology: Advances and Applications 2010, 2:131-134

Published Date: 24 June 2010

Original Research

Clinical outcomes of antimicrobial lock solutions used in a treatment modality: a retrospective case series analysis

P Brandon Bookstaver, Katherine R Gerrald, Robert R Moran

Clinical Pharmacology: Advances and Applications 2010, 2:123-130

Published Date: 17 June 2010

Review

Somatotropin in the treatment of growth hormone deficiency and Turner syndrome in pediatric patients: a review

Christina Southern Reh, Mitchell E Geffner

Clinical Pharmacology: Advances and Applications 2010, 2:111-122

Published Date: 1 June 2010

Original Research

A common variant in the adiponectin gene on weight loss and body composition under sibutramine therapy in obesity

Tun-Jen Hsiao, Lawrence Shih-Hsin Wu, Shih-Yi Huang, et al

Clinical Pharmacology: Advances and Applications 2010, 2:105-110

Published Date: 22 June 2010

Review

A review on the rationale and clinical use of concomitant rosuvastatin and fenofibrate/fenofibric acid therapy

Joe D Strain, Debra K Farver, James R Clem

Clinical Pharmacology: Advances and Applications 2010, 2:95-104

Published Date: 24 May 2010

Original Research

Lanthanum carbonate is not associated with QT interval modification in hemodialysis patients

Biagio Di Iorio, Emanuele Cucciniello

Clinical Pharmacology: Advances and Applications 2010, 2:89-93

Published Date: 1 June 2010

Original Research

Effect of rosiglitazone and ramipril on macrovasculopathy in patients with type 2 diabetes: needs longer treatment and/or higher doses?

Sayeeda Rahman, Aziz Al-Shafi Ismail, Shaiful Bhari Ismail, et al

Clinical Pharmacology: Advances and Applications 2010, 2:83-87

Published Date: 20 April 2010

Review

Cosyntropin as a diagnostic agent in the screening of patients for adrenocortical insufficiency

David D Hamilton, Bryan A Cotton

Clinical Pharmacology: Advances and Applications 2010, 2:77-82

Published Date: 27 April 2010

Mini-review

Induction chemotherapy before autologous stem cell transplantation for symptomatic plasma cell myeloma – does it matter?

Henry C Fung, Sunita Nathan, John J Maciejewski

Clinical Pharmacology: Advances and Applications 2010, 2:71-75

Published Date: 14 April 2010

Perspectives

Lidocaine 5% patch for localized neuropathic pain: progress for the patient, a new approach for the physician

Guy Hans, Dominique Robert, Johanna Verhulst, et al

Clinical Pharmacology: Advances and Applications 2010, 2:65-70

Published Date: 30 March 2010

Original Research

Adverse drug effects in hospitalized elderly: Data from the Healthcare Cost and Utilization Project

Tatyana Shamliyan

Clinical Pharmacology: Advances and Applications 2010, 2:41-63

Published Date: 10 May 2010

Original Research

NMDA receptors are expressed by small-cell lung cancer and are potential targets for effective treatment

William G North, Guohong Gao, Amy Jensen, et al

Clinical Pharmacology: Advances and Applications 2010, 2:31-40

Published Date: 1 April 2010

Mini-review

Pharmacologic agents for smoking cessation: A clinical review

Dilip R Patel, Cynthia Feucht, Lesley Reid, et al

Clinical Pharmacology: Advances and Applications 2010, 2:17-29

Published Date: 7 April 2010

Review

Nanoparticle-labeled stem cells: a novel therapeutic vehicle

Abir O El-Sadik, Afaf El-Ansary, Sherif M Sabry

Clinical Pharmacology: Advances and Applications 2010, 2:9-16

Published Date: 16 March 2010

Original Research

The pharmacokinetics of valganciclovir prophylaxis in pediatric solid organ transplant patients at risk for Epstein–Barr virus disease

Heather E Vezina, Richard C Brundage, Thomas E Nevins, et al

Clinical Pharmacology: Advances and Applications 2010, 2:1-7

Published Date: 22 December 2009

Rapid Communication

Chronic fluoxetine treatment increases daytime melatonin synthesis in the rodent

Gillian W Reierson, Claudio A Mastronardi, Julio Licinio, et al

Clinical Pharmacology: Advances and Applications 2009, 1:1-6

Published Date: 7 September 2009